Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thabo Lengana

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-AfricansMike Sathekge, Thabo Lengana, Alex Maes, et al.
Nuclear Medicine Communications|December 22, 2016
Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinomaIsmaheel O Lawal, Nozipho E Nyakale, Lerwine M Harry, et al.
Hellenic Journal of Nuclear Medicine|July 12, 2017
Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in AfricaIsmaheel O Lawal, Kehinde O Ololade, Thabo Lengana, et al.
Plos One|April 19, 2019
Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parametersIsmaheel O Lawal, Thabo Lengana, Charl Janse van Rensburg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 8, 2019
Impact of optimized PET imaging conditions on <sup>18</sup>F-FDG uptake quantification in patients with apparently normal aortasIsmaheel O Lawal, Kgomotso G Mokoala, Gbenga O Popoola, et al.
Journal of Clinical Medicine|September 10, 2021
Pattern of Prostate Cancer Recurrence Assessed by <sup>68</sup>Ga-PSMA-11 PET/CT in Men Treated with Primary Local TherapyIsmaheel O Lawal, Thabo Lengana, Gbenga O Popoola, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Impact of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer ManagementAsim Afaq, Suliman Alahmed, Shih-Hsin Chen, et al.
Medicine|November 25, 2020
FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort studyIsmaheel O Lawal, Akintunde T Orunmuyi, Gbenga O Popoola, et al.
Hellenic Journal of Nuclear Medicine|December 13, 2021
A comparison of the diagnostic performance of <sup>18</sup>F-PSMA-1007 and <sup>68</sup>GA-PSMA-11 in the same patients presenting with early biochemical recurrenceThabo Lengana, Ismaheel O Lawal, CharlJanse Van Rensburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
<sup>18</sup>F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary TuberculosisIsmaheel O Lawal, Bernard P Fourie, Matsontso Mathebula, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-AfricansMike Sathekge, Thabo Lengana, Alex Maes, et al.
Nuclear Medicine Communications|December 22, 2016
Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinomaIsmaheel O Lawal, Nozipho E Nyakale, Lerwine M Harry, et al.
Hellenic Journal of Nuclear Medicine|July 12, 2017
Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in AfricaIsmaheel O Lawal, Kehinde O Ololade, Thabo Lengana, et al.
Plos One|April 19, 2019
Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parametersIsmaheel O Lawal, Thabo Lengana, Charl Janse van Rensburg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 8, 2019
Impact of optimized PET imaging conditions on <sup>18</sup>F-FDG uptake quantification in patients with apparently normal aortasIsmaheel O Lawal, Kgomotso G Mokoala, Gbenga O Popoola, et al.
Journal of Clinical Medicine|September 10, 2021
Pattern of Prostate Cancer Recurrence Assessed by <sup>68</sup>Ga-PSMA-11 PET/CT in Men Treated with Primary Local TherapyIsmaheel O Lawal, Thabo Lengana, Gbenga O Popoola, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Impact of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer ManagementAsim Afaq, Suliman Alahmed, Shih-Hsin Chen, et al.
Medicine|November 25, 2020
FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort studyIsmaheel O Lawal, Akintunde T Orunmuyi, Gbenga O Popoola, et al.
Hellenic Journal of Nuclear Medicine|December 13, 2021
A comparison of the diagnostic performance of <sup>18</sup>F-PSMA-1007 and <sup>68</sup>GA-PSMA-11 in the same patients presenting with early biochemical recurrenceThabo Lengana, Ismaheel O Lawal, CharlJanse Van Rensburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
<sup>18</sup>F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary TuberculosisIsmaheel O Lawal, Bernard P Fourie, Matsontso Mathebula, et al.
Pageof 4